Neltner et al determine the extent to which individuals selected by manufacturers to make “generally recognized as safe” determinations have conflicts of interest between their obligations to ensure that the use of the additive is safe and their financial relationships to the company. Nestle provides an Invited Commentary on the topic.
Zimlichman and colleagues estimate costs associated with the most significant and targetable health care–associated infections. Katz comments in a related Editor’s Note.
Goldfeld et al compare the patterns of care and quality outcomes observed with Medicare and fee-for-service insurance programs on the care of nursing home patients with advanced dementia. Hall provides an invited commentary.
Likosky et al compare expenditures in 1998 through 1999 and 2008 for Medicare beneficiaries hospitalized for acute myocardial infarction. See the invited commentary by Jha.
Schiff and coauthors study patterns of primary care malpractice types, causes, and outcomes as part of a Massachusetts ambulatory malpractice risk and safety improvement project. See Invited Commentary by Hyman and Sage.
Walling et al evaluate nonhospice supportive cancer care comprehensively in a national sample of veterans. See also the invited commentary by Aldridge and Meier.
This cross-sectional survey study characterizes what physicians tell their patients about the possibility of overdiagnosis and overtreatment when discussing cancer screening.